MGTX vs ODTX
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
MGTX · MeiraGTx Holdings$7.98 ▼ 1.97%
ODTX · Odyssey Therapeutics$16.96 ▼ 7.52%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- MGTX -18.7%
- ODTX +3.3%
Head to head
| Metric | MGTX | ODTX |
|---|---|---|
| Price | $7.98 | $16.96 |
| Change today | ▼ 1.97% | ▼ 7.52% |
| Market cap | $779.89M | $815.23M |
| Return, 3 months | -46.2% | -32.6% |
| Return, year to date | +0.4% | – |
| Return, 1 year | +7.0% | – |
| P/E (TTM) | 9.2 | – |
| P/B | 3.6 | 2.2 |
| P/E percentile vs own 5y | 95th | 93rd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +1,074.1% | -100.0% |
| Net profit growth (YoY) | -1.5% | -49.6% |
| Gross margin | 97.2% | – |
| Operating margin | 44.8% | – |
| Net margin | 19.5% | – |
| Return on equity | 89.7% | -47.3% |
| Analyst target vs. price | +180.7% | +111.1% |
| Analyst buy share | 80% | 100% |
| RSI (14) | 33 | 36 |
| 30-day volatility | 67.2% | 68.5% |
| Max drawdown, 1 year | -46.7% | -42.3% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ODTX is the largest of the group by market value.
- MGTX is growing revenue fastest.
- MGTX has been the calmest stock over the last 30 days.